A detailed history of Private Wealth Partners, LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Private Wealth Partners, LLC holds 6,240 shares of VKTX stock, worth $309,379. This represents 0.03% of its overall portfolio holdings.

Number of Shares
6,240
Previous 5,000 24.8%
Holding current value
$309,379
Previous $265,000 49.06%
% of portfolio
0.03%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$49.84 - $70.47 $61,801 - $87,382
1,240 Added 24.8%
6,240 $395,000
Q2 2024

Aug 07, 2024

BUY
$47.39 - $80.2 $236,950 - $401,000
5,000 New
5,000 $265,000

Others Institutions Holding VKTX

About Viking Therapeutics, Inc.


  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $3.8B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Private Wealth Partners, LLC Portfolio

Follow Private Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Wealth Partners, LLC with notifications on news.